Your browser doesn't support javascript.
loading
Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide.
Mashreghi, Mohammad; Faal Maleki, Mahdi; Karimi, Maryam; Kalalinia, Fatemeh; Badiee, Ali; Jaafari, Mahmoud Reza.
Afiliación
  • Mashreghi M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Faal Maleki M; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Karimi M; Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Kalalinia F; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Badiee A; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Jaafari MR; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
J Drug Target ; 29(6): 617-630, 2021 07.
Article en En | MEDLINE | ID: mdl-33393376

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Sistemas de Liberación de Medicamentos / Inhibidores de la Angiogénesis / Antibióticos Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: J Drug Target Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Sistemas de Liberación de Medicamentos / Inhibidores de la Angiogénesis / Antibióticos Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: J Drug Target Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Irán
...